Nori Mehta

Vice President at Analysis Group

Speaker

Ms. Mehta specializes in conducting complex economic analyses related to healthcare litigation, health policy, and health economics and outcomes research (HEOR). In her healthcare litigation work, Ms. Mehta has leveraged her extensive experience with large datasets, including government and private administrative claims records, to analyze a range of issues, including those related to alleged kickbacks, off-label marketing, market definition and antitrust, but-for pricing and sales, and competitive effects. In her health policy work, Ms. Mehta has assessed policies that impact drug innovation, including the Inflation Reduction Act’s Medicare Part D Drug Price Negotiation Program. In her HEOR work, Ms. Mehta has conducted research on the economic value of a respiratory syncytial virus (RSV) vaccine in an elder population and has designed algorithms to support the execution of value-based contracts across multiple disease states and treatment areas, among other projects.